Global and United States Chagas Disease Drug Market Insights, Forecast to 2026

Global and United States Chagas Disease Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Chagas Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Chagas Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chagas Disease Drug Market Size Growth Rate by Type
1.4.2 Cz-007
1.4.3 Cz-008
1.4.4 D-121
1.4.5 DNDI-0690
1.4.6 EPLBS-1246
1.4.7 EPLBS-967
1.4.8 Others
1.5 Market by Application
1.5.1 Global Chagas Disease Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Chagas Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Chagas Disease Drug Revenue 2015-2026
2.1.2 Global Chagas Disease Drug Sales 2015-2026
2.2 Global Chagas Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Chagas Disease Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Chagas Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Chagas Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Chagas Disease Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Chagas Disease Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Chagas Disease Drug Revenue Forecast by Region (2021-2026)
3 Global Chagas Disease Drug Competitor Landscape by Players
3.1 Global Top Chagas Disease Drug Sales by Manufacturers
3.1.1 Global Chagas Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Chagas Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Chagas Disease Drug Manufacturers by Revenue
3.2.1 Global Chagas Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Chagas Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chagas Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chagas Disease Drug Revenue in 2019
3.2.5 Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chagas Disease Drug Price by Manufacturers
3.4 Global Chagas Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Chagas Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chagas Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Chagas Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chagas Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Chagas Disease Drug Sales by Type (2015-2020)
4.1.2 Global Chagas Disease Drug Revenue by Type (2015-2020)
4.1.3 Chagas Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chagas Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Chagas Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Chagas Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Chagas Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chagas Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Chagas Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Chagas Disease Drug Sales by Application (2015-2020)
5.1.2 Global Chagas Disease Drug Revenue by Application (2015-2020)
5.1.3 Chagas Disease Drug Price by Application (2015-2020)
5.2 Chagas Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Chagas Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Chagas Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Chagas Disease Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Chagas Disease Drug Market Size YoY Growth 2015-2026
6.1.1 United States Chagas Disease Drug Sales YoY Growth 2015-2026
6.1.2 United States Chagas Disease Drug Revenue YoY Growth 2015-2026
6.1.3 United States Chagas Disease Drug Market Share in Global Market 2015-2026
6.2 United States Chagas Disease Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Chagas Disease Drug Players by Sales (2015-2020)
6.2.2 United States Top Chagas Disease Drug Players by Revenue (2015-2020)
6.3 United States Chagas Disease Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Chagas Disease Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Chagas Disease Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Chagas Disease Drug Price by Type (2015-2020)
6.4 United States Chagas Disease Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Chagas Disease Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Chagas Disease Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Chagas Disease Drug Price Forecast by Type (2021-2026)
6.5 United States Chagas Disease Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Chagas Disease Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Chagas Disease Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Chagas Disease Drug Price by Application (2015-2020)
6.6 United States Chagas Disease Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Chagas Disease Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Chagas Disease Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Chagas Disease Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Chagas Disease Drug Market Size YoY Growth 2015-2026
7.2 North America Chagas Disease Drug Market Facts & Figures by Country
7.2.1 North America Chagas Disease Drug Sales by Country (2015-2020)
7.2.2 North America Chagas Disease Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Chagas Disease Drug Market Size YoY Growth 2015-2026
8.2 Europe Chagas Disease Drug Market Facts & Figures by Country
8.2.1 Europe Chagas Disease Drug Sales by Country
8.2.2 Europe Chagas Disease Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Chagas Disease Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Chagas Disease Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Chagas Disease Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Chagas Disease Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Chagas Disease Drug Market Size YoY Growth 2015-2026
10.2 Latin America Chagas Disease Drug Market Facts & Figures by Country
10.2.1 Latin America Chagas Disease Drug Sales by Country
10.2.2 Latin America Chagas Disease Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Chagas Disease Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Chagas Disease Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Chagas Disease Drug Sales by Country
11.2.2 Middle East and Africa Chagas Disease Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Corporation Information
12.1.2 AstraZeneca Plc Description and Business Overview
12.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc Chagas Disease Drug Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 Bayer AG
12.2.1 Bayer AG Corporation Information
12.2.2 Bayer AG Description and Business Overview
12.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer AG Chagas Disease Drug Products Offered
12.2.5 Bayer AG Recent Development
12.3 Daiichi Sankyo Co Ltd
12.3.1 Daiichi Sankyo Co Ltd Corporation Information
12.3.2 Daiichi Sankyo Co Ltd Description and Business Overview
12.3.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Products Offered
12.3.5 Daiichi Sankyo Co Ltd Recent Development
12.4 Eisai Co Ltd
12.4.1 Eisai Co Ltd Corporation Information
12.4.2 Eisai Co Ltd Description and Business Overview
12.4.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eisai Co Ltd Chagas Disease Drug Products Offered
12.4.5 Eisai Co Ltd Recent Development
12.5 GlaxoSmithKline Plc
12.5.1 GlaxoSmithKline Plc Corporation Information
12.5.2 GlaxoSmithKline Plc Description and Business Overview
12.5.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Plc Chagas Disease Drug Products Offered
12.5.5 GlaxoSmithKline Plc Recent Development
12.6 Grupo Praxis Pharmaceutical SA
12.6.1 Grupo Praxis Pharmaceutical SA Corporation Information
12.6.2 Grupo Praxis Pharmaceutical SA Description and Business Overview
12.6.3 Grupo Praxis Pharmaceutical SA Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Products Offered
12.6.5 Grupo Praxis Pharmaceutical SA Recent Development
12.7 Humanigen Inc
12.7.1 Humanigen Inc Corporation Information
12.7.2 Humanigen Inc Description and Business Overview
12.7.3 Humanigen Inc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Humanigen Inc Chagas Disease Drug Products Offered
12.7.5 Humanigen Inc Recent Development
12.8 Kancera AB
12.8.1 Kancera AB Corporation Information
12.8.2 Kancera AB Description and Business Overview
12.8.3 Kancera AB Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Kancera AB Chagas Disease Drug Products Offered
12.8.5 Kancera AB Recent Development
12.9 Merck & Co Inc
12.9.1 Merck & Co Inc Corporation Information
12.9.2 Merck & Co Inc Description and Business Overview
12.9.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Merck & Co Inc Chagas Disease Drug Products Offered
12.9.5 Merck & Co Inc Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Description and Business Overview
12.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis AG Chagas Disease Drug Products Offered
12.10.5 Novartis AG Recent Development
12.11 AstraZeneca Plc
12.11.1 AstraZeneca Plc Corporation Information
12.11.2 AstraZeneca Plc Description and Business Overview
12.11.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Plc Chagas Disease Drug Products Offered
12.11.5 AstraZeneca Plc Recent Development
12.12 Sanofi
12.12.1 Sanofi Corporation Information
12.12.2 Sanofi Description and Business Overview
12.12.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sanofi Products Offered
12.12.5 Sanofi Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Chagas Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chagas Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Chagas Disease Drug Market Segments
Table 2. Ranking of Global Top Chagas Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chagas Disease Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cz-007
Table 5. Major Manufacturers of Cz-008
Table 6. Major Manufacturers of D-121
Table 7. Major Manufacturers of DNDI-0690
Table 8. Major Manufacturers of EPLBS-1246
Table 9. Major Manufacturers of EPLBS-967
Table 10. Major Manufacturers of Others
Table 11. Global Chagas Disease Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Chagas Disease Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Chagas Disease Drug Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Chagas Disease Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Chagas Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Chagas Disease Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 17. Global Chagas Disease Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Chagas Disease Drug Sales Share by Manufacturers (2015-2020)
Table 19. Global Chagas Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Drug as of 2019)
Table 21. Chagas Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Chagas Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Chagas Disease Drug Price (2015-2020) (USD/Pcs)
Table 24. Chagas Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Chagas Disease Drug Product Type
Table 26. Date of International Manufacturers Enter into Chagas Disease Drug Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 29. Global Chagas Disease Drug Sales Share by Type (2015-2020)
Table 30. Global Chagas Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Chagas Disease Drug Revenue Share by Type (2015-2020)
Table 32. Chagas Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Chagas Disease Drug Sales Share by Type (2021-2026)
Table 34. Global Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 35. Global Chagas Disease Drug Sales Share by Application (2015-2020)
Table 36. Global Chagas Disease Drug Sales Share by Application (2021-2026)
Table 37. Global Chagas Disease Drug Sales Market Share Forecast by Application (2021-2026)
Table 38. Global Chagas Disease Drug Revenue by Application (2015-2020) (US$ Million)
Table 39. Global Chagas Disease Drug Revenue Market Share Forecast by Application (2021-2026)
Table 40. United States Chagas Disease Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 41. United States Chagas Disease Drug Sales Share by Company (2015-2020)
Table 42. United States Chagas Disease Drug Revenue (US$ Million) by Company (2015-2020)
Table 43. United States Chagas Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 44. United States Chagas Disease Drug Sales Share by Type (2015-2020)
Table 45. United States Chagas Disease Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 46. United States Chagas Disease Drug Price (K Pcs) by Type (2015-2020)
Table 47. United States Chagas Disease Drug Sales (K Pcs) by Type (2021-2026)
Table 48. United States Chagas Disease Drug Sales Share by Type (2021-2026)
Table 49. United States Chagas Disease Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 50. United States Chagas Disease Drug Revenue Share by Type (2021-2026)
Table 51. United States Chagas Disease Drug Price (K Pcs) by Type (2021-2026)
Table 52. United States Chagas Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 53. United States Chagas Disease Drug Sales Share by Application (2015-2020)
Table 54. United States Chagas Disease Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 55. United States Chagas Disease Drug Sales (K Pcs) by Application (2021-2026)
Table 56. United States Chagas Disease Drug Sales Share by Application (2021-2026)
Table 57. United States Chagas Disease Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 58. United States Chagas Disease Drug Revenue Share by Application (2021-2026)
Table 59. North America Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 60. North America Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 61. North America Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 62. North America Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 63. Europe Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Europe Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 65. Europe Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Europe Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 67. Asia Pacific Chagas Disease Drug Sales by Region (2015-2020) (K Pcs)
Table 68. Asia Pacific Chagas Disease Drug Sales Market Share by Region (2015-2020)
Table 69. Asia Pacific Chagas Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 70. Asia Pacific Chagas Disease Drug Revenue Market Share by Region (2015-2020)
Table 71. Latin America Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 72. Latin America Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 73. Latin Americaa Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 74. Latin America Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 75. Middle East and Africa Chagas Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 76. Middle East and Africa Chagas Disease Drug Sales Market Share by Country (2015-2020)
Table 77. Middle East and Africa Chagas Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 78. Middle East and Africa Chagas Disease Drug Revenue Market Share by Country (2015-2020)
Table 79. AstraZeneca Plc Corporation Information
Table 80. AstraZeneca Plc Description and Business Overview
Table 81. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. AstraZeneca Plc Chagas Disease Drug Product
Table 83. AstraZeneca Plc Recent Development
Table 84. Bayer AG Corporation Information
Table 85. Bayer AG Description and Business Overview
Table 86. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Bayer AG Product
Table 88. Bayer AG Recent Development
Table 89. Daiichi Sankyo Co Ltd Corporation Information
Table 90. Daiichi Sankyo Co Ltd Description and Business Overview
Table 91. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Daiichi Sankyo Co Ltd Product
Table 93. Daiichi Sankyo Co Ltd Recent Development
Table 94. Eisai Co Ltd Corporation Information
Table 95. Eisai Co Ltd Description and Business Overview
Table 96. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Eisai Co Ltd Product
Table 98. Eisai Co Ltd Recent Development
Table 99. GlaxoSmithKline Plc Corporation Information
Table 100. GlaxoSmithKline Plc Description and Business Overview
Table 101. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. GlaxoSmithKline Plc Product
Table 103. GlaxoSmithKline Plc Recent Development
Table 104. Grupo Praxis Pharmaceutical SA Corporation Information
Table 105. Grupo Praxis Pharmaceutical SA Description and Business Overview
Table 106. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Grupo Praxis Pharmaceutical SA Product
Table 108. Grupo Praxis Pharmaceutical SA Recent Development
Table 109. Humanigen Inc Corporation Information
Table 110. Humanigen Inc Description and Business Overview
Table 111. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Humanigen Inc Product
Table 113. Humanigen Inc Recent Development
Table 114. Kancera AB Corporation Information
Table 115. Kancera AB Description and Business Overview
Table 116. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Kancera AB Product
Table 118. Kancera AB Recent Development
Table 119. Merck & Co Inc Corporation Information
Table 120. Merck & Co Inc Description and Business Overview
Table 121. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Merck & Co Inc Product
Table 123. Merck & Co Inc Recent Development
Table 124. Novartis AG Corporation Information
Table 125. Novartis AG Description and Business Overview
Table 126. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Novartis AG Product
Table 128. Novartis AG Recent Development
Table 129. Oblita Therapeutics BVBA Corporation Information
Table 130. Oblita Therapeutics BVBA Description and Business Overview
Table 131. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Oblita Therapeutics BVBA Product
Table 133. Oblita Therapeutics BVBA Recent Development
Table 134. Sanofi Corporation Information
Table 135. Sanofi Description and Business Overview
Table 136. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Sanofi Product
Table 138. Sanofi Recent Development
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Chagas Disease Drug Players
Table 143. Chagas Disease Drug Customers List
Table 144. Chagas Disease Drug Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Chagas Disease Drug Product Picture
Figure 2. Global Chagas Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Cz-007 Product Picture
Figure 4. Cz-008 Product Picture
Figure 5. D-121 Product Picture
Figure 6. DNDI-0690 Product Picture
Figure 7. EPLBS-1246 Product Picture
Figure 8. EPLBS-967 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Chagas Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Chagas Disease Drug Report Years Considered
Figure 15. Global Chagas Disease Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Chagas Disease Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Chagas Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Chagas Disease Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Chagas Disease Drug Sales Market Share by Region in 2019
Figure 20. Global Chagas Disease Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Chagas Disease Drug Revenue Market Share by Region in 2019
Figure 22. Global Chagas Disease Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Chagas Disease Drug Revenue in 2019
Figure 24. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Chagas Disease Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Chagas Disease Drug Sales Market Share by Type in 2019
Figure 27. Global Chagas Disease Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Chagas Disease Drug Revenue Market Share by Type in 2019
Figure 29. Global Chagas Disease Drug Market Share by Price Range (2015-2020)
Figure 30. Global Chagas Disease Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Chagas Disease Drug Sales Market Share by Application in 2019
Figure 32. Global Chagas Disease Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Chagas Disease Drug Revenue Market Share by Application in 2019
Figure 34. United States Chagas Disease Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. United States Chagas Disease Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. United States Chagas Disease Drug Market Share in Global Market 2015-2026
Figure 37. United States 5 and 10 Largest Chagas Disease Drug Players Market Share by Revenue in Chagas Disease Drug in 2019
Figure 38. United States Chagas Disease Drug Revenue Share by Type (2015-2020)
Figure 39. United States Chagas Disease Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 40. United States Chagas Disease Drug Revenue Share by Application (2015-2020)
Figure 41. United States Chagas Disease Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Chagas Disease Drug Sales Market Share by Country in 2019
Figure 45. North America Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 46. U.S. Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Chagas Disease Drug Sales Market Share by Country in 2019
Figure 53. Europe Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 54. Germany Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Chagas Disease Drug Sales Market Share by Region in 2019
Figure 67. Asia Pacific Chagas Disease Drug Revenue Market Share by Region in 2019
Figure 68. China Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Chagas Disease Drug Sales Market Share by Country in 2019
Figure 93. Latin America Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 94. Mexico Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa Chagas Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Chagas Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Chagas Disease Drug Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Chagas Disease Drug Revenue Market Share by Country in 2019
Figure 104. Turkey Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Chagas Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Chagas Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. Chagas Disease Drug Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs